x
Dartmouth-Hitchcock logo
Summer Flowers In This Section
 
A Prospective, Multicenter, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Safety and Efficacy of Preoperative Antithrombin Supplementation in Patients Undergoing High-Risk Cardiac Surgery with Cardiopulmonary Bypass
Principal Investigator (?)
Study Number
F16195
Summary
This is a prospective, multicenter, randomized, double-blind, placebo-controlled study. The purpose of this study is to determine the safety and effectiveness of human-derived antithrombin III (AT-III [Human]) supplementation prior to high-risk, non-emergency, cardiac surgery with cardiopulmonary bypass (CPB). A total of 404 adult subjects undergoing CPB who meet the study eligibility criteria will be randomized to receive either AT-III (Human) or placebo. 
Phase (?)
Phase III
Sponsor (?)
Contact

Gaylin Petty

Available at the following location(s)

Lebanon

View more details from ClinicalTrials.gov.

0